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Focal Hepatic Lesions: Contrast-
Enhancement Patterns at Pulse-Inversion
Harmonic US using a Microbubble
Contrast Agent
Objective: To analyze the contrast-enhancement patterns obtained at pulse-
inversion harmonic imaging (PIHI) of focal hepatic lesions, and to thus determine
tumor vascularity and the acoustic emission effect.
Materials and Methods: We reviewed pulse-inversion images in 90 consecu-
tive patients with focal hepatic lesions, namely hepatocellular carcinoma (HCC)
(n=43), metastases (n=30), and hemangioma (n=17). Vascular and delayed
phase images were obtained immediately and five minutes following the injection
of a microbubble contrast agent. Tumoral vascularity at vascular phase imaging
and the acoustic emission effect at delayed phase imaging were each classified
as one of four patterns.
Results: Vascular phase images depicted internal vessels in 93% of HCCs,
marginal vessels in 83% of metastases, and peripheral nodular enhancement in
71% of hemangiomas. Delayed phase images showed inhomogeneous
enhancement in 86% of HCCs; hypoechoic, decreased enhancement in 93% of
metastases; and hypoechoic and reversed echogenicity in 65% of hemangiomas.
Vascular and delayed phase enhancement patterns were associated with a
specificity of 91% or greater, and 92% or greater, respectively, and with positive
predictive values of 71% or greater, and 85% or greater, respectively.
Conclusion: Contrast-enhancement patterns depicting tumoral vascularity and
the acoustic emission effect at PIHI can help differentiate focal hepatic lesions.
ltrasonography (US) has been used as a non-invasive imaging technique
for the detection, characterization and staging of focal hepatic lesions.
Unfortunately, since most tumors have nonspecific morphologic features,
the usefulness of US for the characterization of hepatic masses is limited. Although
color and power Doppler US can provide vascular information, they are less sensitive
than angiography for the detection of small vessels, and suffer limitations when hepat-
ic masses are small. Both these modalities are also subject to motion artifacts arising
from respiratory and cardiac activity (1, 2).
New ultrasound imaging technologies such as the harmonic technique (3), used with
various sonographic contrast agents (4 9), are able to overcome the limitations of
conventional and Doppler US. When used with a microbubble contrast agent, pulse-in-
version harmonic imaging (PIHI) relies on the asymmetric oscillation of ultrasound
bubbles in an acoustic field (10), and used in conjunction with a low mechanical index
(MI) technique, allows nondestructive, continuous imaging after injection of a mi-
crobubble agent; it can also detect blood flow in the capillary bed within the tumor
(tumoral vascularity). In addition, a high-MI technique destroys accumulated mi-
crobubbles, causing them to release high-intensity, nonlinear ultrasound echoes which
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Ucan be optimally detected by delayed phase imaging (10,
11).
Previous studies have demonstrated that compared with
conventional US and spiral CT, the use of stimulated
acoustic emission imaging improves the conspicuity of he-
patic metastases (12, 13). A number of recent studies have
reported the value of contrast-enhanced harmonic imaging
for the characterization of blood flow in focal hepatic le-
sions (11, 14 17), but none have described the use of both
vascular and delayed phase P1H1 imaging for the charac-
terization of focal hepatic lesions. The purpose of this
study is to describe our experience in categorizing focal he-
patic lesions on the basis of patterns of tumoral vascularity,
as seen at low-MI continuous imaging, as well as the pat-
terns of acoustic emission effect observed at delayed phase
imaging with a high MI after injection of a microbubble
contrast agent.
MATERIALS AND METHODS
Subjects
Between September 2000 and August 2001, 135 consec-
utive patients with hepatic masses underwent pulse-inver-
sion harmonic US. A confirmed diagnosis of hepatic mass
in one of three categories - hepatocellular carcinoma
(HCC), metastasis, or hemangioma - was the only criterion
for inclusion. Patients in whom HCC had been treated by
transarterial chemoembolization or radiofrequency abla-
tion prior to US examination (n=21), or had a dysplastic
nodule (n=8), inflammatory eosinophilic granuloma (n=4)
or focal nodular hyperplasia (n=2), were excluded, as
were those (n=10) for whom chemotherapy was ongoing
or had been performed within the previous 30 days. Thus,
90 patients [60 men and 30 women; mean age, 57 (range
23 79) years] with focal hepatic lesions, including HCC
(n=43), metastasis (n=30) and hemangioma (n=17), were
included in this study. Informed consent was obtained from
all patients and the approval of our institutional review
board was obtained.
Five patients with HCCs and 22 with metastases had
multiple (two to seven) lesions. In patients with multiple
HCCs or metastatic lesions, only one dominant lesion per
patient was analyzed (determined on the basis of size). A
diagnosis of HCC was confirmed by US-guided percuta-
neous needle biopsy in 24 patients and at surgery in three.
In the remaining 16 patients, HCC was diagnosed on the
basis of the typical imaging findings of three-phase helical
CT, angiography and/or CT after intra-arterial injection of
iodized oil, as well as elevated levels of serum alpha-feto-
protein (> 200 ng/mL). For metastatic liver tumors, the
sites of primary disease were the stomach (n=13), colon
(n=10), pancreas (n=5) and lung (n=2). Radiological or
histological study showed that no metastatic lesion was hy-
pervascular. For 27 of the 30 patients with hepatic metas-
tases, the diagnosis was histologically confirmed at surgery
(n=7) or by biopsy (n=20). In the remaining three cases,
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Fig. 1. The contrast-enhancement pat-
terns observed at vascular phase pulse-
inversion harmonic imaging of hepatic tu-
mors.diagnosis was based on follow-up serial CT findings show-
ing that the lesions had progressed rapidly. All patients
with hemangioma underwent dynamic contrast-enhanced
CT (n=17) or MR (n=9) examination. For 16 of the 17 he-
mangiomas, diagnosis was based on typical imaging find-
ings; the other was diagnosed at biopsy. The HCCs ranged
in size from 1.0 to 7.0 (mean, 3.5) cm, metastases from 1.0
to 6.0 (mean, 2.9) cm, and hemangiomas from 1.0 to 4.0
(mean, 2.4) cm.
US Examination
Pulse-inversion harmonic US was performed by one in-
vestigator (K.H.Y.), using a commercially available US sys-
tem (HDI-5000; Advanced Technology Laboratory,
Bothell, Washington, U.S.A.) together with a 5 2 MHz
curved linear-array transducer. To assess tumor vasculari-
ty, continuous low-MI imaging (< 0.3) was performed im-
mediately following injection and during the delivery of a
microbubble contrast agent (the first 60-second period af-
ter contrast injection). The second contrast agent was in-
jected five minutes after the first. Five minutes later, high-
MI (1.0 1.3) delayed phase images were obtained, and the
acoustic emission effect thus determined. During the inter-
val between the vascular phase and delayed phase, the dis-
play was frozen and ‘interval-delay scanning’ was not per-
formed. The microbubble contrast agent used was SH U
508 A (Levovist; Schering, Berlin, Germany), a 2.5 gm bo-
lus of which was injected twice, for vascular and delayed
imaging, at a concentration of 300 mg/mL followed by a
10-mL normal saline flush using a 20-gauge peripheral in-
travenous cannula.
When the area of interest was identified at conventional
US, PIHI was activated, with the focal zone set at or just
deeper than the level of interest. All imaging was per-
formed with the transducer in a constant position over the
region of interest in order to depict the lesion and to in-
clude some normal liver. While the contrast agent was be-
ing delivered, during a period of shallow breathing, scan-
ning was performed and the enhanced blood signals in
both normal hepatic blood vessels and lesional blood ves-
sels were depicted. During low-MI imaging, a medium
frame rate was set (8 per second). High-MI scanning, on
the other hand, was performed during the shortest possible
period (and with breath-hold), in order to reduce the
amount of microbubble disruption in the region of interest
outside, and the display was then frozen. In order to de-
stroy microbubbles with insonation and to identify white
flashes of contrast break-up, we used a medium pulse
length, the maximum mechanical index, a high frame rate
(15 per second) and low line density. After freezing the
display, we reviewed the images using a cine loop and
stored the strongest effects seen during the first and second
Kim et al.
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Fig. 2. The contrast-enhancement patterns seen at delayed phase pulse-inversion harmonic imaging of hepatic tumors.frames. All studies were recorded on S-VHS video, and
with selected digital images and cine loops were stored on
a magneto-optical disk.
Image Analysis
Ultrasonic images were reviewed retrospectively by
three radiologists (E.A.K., S.K.J., J.J.W.), who were un-
aware of the pathologic diagnosis or other radiologic imag-
ing findings. Each had more than five years of experience
of ultrasonography involving the use of contrast agents.
The reviewers determined the diameters and echogenici-
ty of the tumors, as seen on unenhanced conventional and
pre-contrast pulse-inversion harmonic images. The pattern
of contrast enhancement of each tumor depicted by dual-
phase pulse-inversion harmonic US was evaluated by ex-
amining the images obtained during the vascular phase of
enhancement (typically 20 60 seconds after contrast injec-
tion), and during the delayed phase (5 minutes after a sep-
arate injection of contrast agent). All observations of en-
hancement patterns were totally subjective. In each pa-
tient, tumoral vascularity of the dominant lesion, as seen
on vascular phase images, was classified as one of four pat-
terns, as follows (Fig. 1). The presence of linear or
branched internal vessels was categorized as the ‘internal
vessels’ pattern; that of linear or dot-like marginal vessels
at the periphery of the tumor, regardless of the presence or
absence of central vessels, as the ‘marginal vessels’ pattern;
that of a discrete and well-defined ring of peripheral en-
hancing nodules, as ‘peripheral nodular enhancement’; and
the absence of visible vessels or enhancement in either in-
ternal or peripheral areas of the tumor, as the ‘minimal or
no enhancement’ pattern. The acoustic emission effect
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Fig. 3. Hepatocellular carcinoma showing the ‘internal vessels’ pattern during the vascular phase and ‘inhomogeneous enhancement’
during the delayed phase.
A. Pulse-inversion harmonic US image before injection of the contrast agent depicts a hyperechoic mass (arrow).
B, C. Vascular phase pulse-inversion harmonic US low-MI images obtained 15 sec (B) and 45 sec (C) after contrast injection depict the
tumor’s internal vessels (arrows).
D. Delayed phase image (high MI) obtained five minutes after contrast injection demonstrates inhomogeneous enhancement (arrow) and
the acoustic emission effect in hepatic parenchyma.
CD
ABwithin the tumor, as seen on delayed phase images, was al-
so classified as one of four patterns (Fig. 2). ‘Inhomoge-
neous enhancement’ was defined as irregular and hetero-
geneous enhancement within the tumor; ‘hypoechoic, de-
creased enhancement’ as the presence of contrast, but de-
creased enhancement with respect to adjacent liver
parenchyma; ‘isoechoic, homogeneous enhancement’ as
homogeneous enhancement, similar to that of adjacent liv-
er parenchyma; and the term ‘hypoechoic and reversed
echogenicity’ was used to describe a tumor represented as
a hyperechoic lesion on unenhanced US images and as a
reversed hypoechoic lesion on delayed phase images.
Agreement regarding the pattern analysis of all lesions
was reached by consensus; disagreements were resolved
by majority opinion. Sensitivity and specificity were deter-
mined for the different histologic diagnoses, and positive
predictive values (PPV) for the various observed enhance-
ment patterns.
RESULTS
Vascular Phase
Vascular phase low-MI enhancement patterns for tu-
moral vascularity in the 90 patients with focal hepatic le-
sions are summarized in Table 1. Forty-four lesions [40
HCCs (91%) and four metastases (9%)] demonstrated the
‘internal vessels’ pattern, while for 27 lesions [25 metas-
tases (93%) and two HCCs (7%)], the ‘marginal vessels’
pattern was observed. Twelve lesions [12 hemangiomas
(100%)] showed peripheral nodular enhancement, and in
seven cases [five hemangiomas (71%), one HCC (14%)
and one metastasis (14%)], the observed pattern was ‘min-
imal or no enhancement’. Table 2 summarizes the vascular
phase enhancement patterns for tumor vascularity associat-
ed with each diagnosis, and the corresponding sensitivity,
specificity, and PPV values. For HCCs, three patterns were
Kim et al.
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Fig. 4. Metastases from colon cancer showing ‘marginal vessels’ and ‘hypoechoic, decreased enhancement’.
A. Pulse-inversion harmonic US image obtained before contrast injection shows a hypoechoic mass (arrow).
B, C. Vascular phase pulse-inversion harmonic US images (low MI) obtained 35 sec (B) and 54 sec (C) after contrast injection depict
marginal tumor vessels (arrows) and some central vessels.
D. Delayed phase image (high MI) shows a hypoechoic mass with decreased enhancement (arrow) compared to the acoustic emission
effect of surrounding normal hepatic parenchyma.
CD
ABobserved: ‘internal vessels’ [93% (40/43) (Fig. 3)];
‘marginal vessels’ [5% (2/43)]; and ‘minimal or no en-
hancement’ [2% (1/43)]. For metastases, the same three
enhancement patterns occurred: ‘internal vessels’ [13%
(4/30)]; ‘marginal vessels’ [83% (25/30) (Fig. 4)]; and ‘min-
imal or no enhancement’ [3% (1/30)], while for heman-
giomas, there were two: ‘peripheral nodular enhancement’
[71% (12/17) (Fig. 5)] and ‘minimal or no enhancement’
[29% (5/17)]. The observed patterns were associated with
a specificity of 91% or greater, and PPVs of 71% or
greater: ‘internal vessels’ for HCCs; ‘marginal vessels’ for
metastases; ‘peripheral nodular enhancement’ for heman-
giomas.
Delayed Phase
Delayed phase high-MI acoustic emission effect patterns
within the tumor are summarized in Table 3. Thirty-nine
lesions [37 HCCs (95%) and two metastases (5%)] demon-
strated inhomogeneous enhancement, while 33[28 metas-
tases (85%) and five HCCs (15%)] showed hypoechoic,
decreased enhancement. In 11 tumors, all of which were
hemangiomas, hypoechoic and reversed echogenecity was
observed, and in seven [six hemangiomas (86%) and one
HCC (14%)], isoechoic, homogeneous enhancement was
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Fig. 5. Hemangioma demonstrating ‘peripheral nodular enhancement’ and ‘isoechoic, homogeneous enhancement’ patterns.
A, B, C. Vascular phase pulse-inversion harmonic US images obtained 24 sec (A), 38 sec (B) and 56 sec (C) after contrast injection de-
pict peripheral nodular enhancement with progressive centripetal fill-in (arrows).
D. Delayed phase image (high MI) demonstrates isoechoic, homogeneous enhancement (arrowheads), which is the same appearance
as normal hepatic parenchyma.
CD
AB
Table 1. Enhancement Patterns for Tumoral Vascularity at
Vascular Phase Pulse-inversion Harmonic US in 90
Patients with HCC, Metastasis, and Hemangioma
Enhancement pattern HCC Metastasis Hemangioma Total
Internal vessels 40 04 004 4
Marginal vessels 022 5 002 7
Peripheral nodular 00 001 2 1 2
enhancement
Minimal or no 01 01 05 07
enhancement
Total 43 30 17 90
Note. HCC=hepatocellular carcinoma.noted.
Table 4 summarizes the delayed phase the acoustic emis-
sion effect patterns associated with each diagnosis, and the
corresponding sensitivity, specificity, and PPV values. For
HCCs, three enhancement patterns were observed: ‘inho-
mogeneous enhancement’ [86% (37/43) (Fig. 3)], ‘hypoe-
choic, decreased enhancement’ [12% (5/43)], and ‘isoe-
choic, homogeneous enhancement’ [2% (1/43)]. For metas-
tases, two patterns were apparent: ‘hypoechoic, decreased
enhancement’ [93% (28/30) (Fig. 6)], and ‘inhomogeneous
enhancement’ [7% (2/30)]. Neither conventional nor unen-
hanced US revealed the presence of a hyperechoic lesion.
Hemangiomas showed two enhancement patterns: ‘hypoe-
choic and reversed echogenicity’ [65% (11/17) (Fig. 7)],
and ‘isoechoic, homogeneous enhancement’ [35% (6/17)
(Fig. 5)]. The above patterns were associated with a speci-
ficity of 92% or greater, and PPVs of 85% or greater:
‘inhomogeneous enhancement’ for HCCs; ‘hypoechoic, de-
creased enhancement’ for metastases; and for heman-
giomas, ‘hypoechoic and reversed echogenicity’ or ‘isoe-
choic, homogeneous enhancement’.
DISCUSSION
This study has demonstrated that vascular phase PIHI
with a low MI and delayed phase PIHI with a high MI after
the administration of a microbubble contrast agent may be
able to differentiate hepatic tumors such as HCC, heman-
gioma, and metastasis. Wilson et al. (11) reported their ini-
tial experience of harmonic hepatic US with microbubble
contrast agent for the characterization of focal hepatic le-
sions. Although their study and ours showed similar re-
sults, ours was different in two respects: firstly, we used SH
U 508 A, which consists of galactose microaggregates with
a small admixture of palmitic acid. Wilson et al., on the
other hand, used a perfluorocarbon microbubble agent,
which is a blood pool contrast agent comprising microbub-
bles stabilized by a protein shell. Although we know of no
comparative studies of the various microbubble contrast
agents, perfluorocarbon agents are more highly regarded
Kim et al.
230 Korean J Radiol 4(4), December 2003
Table 2. Vascular Phase Enhancement Patterns for Each Diagnosis, and the Corresponding Sensitivity, Specificity, and PPV
Values
Diagnosis Enhancement Patterns Sensitivity Specificity PPV
HCC Internal vessels 40/43 (93) 43/47 (91) 40/44 (91)
Metastasis Marginal vessels 25/30 (83)  67/69 (97) 25/27 (93)
Hemangioma Peripheral nodular enhancement 12/17 (71)  073/73 (100) 012/12 (100)
Hemangioma Minimal or no enhancement 05/17 (29) 71/73 (97) 05/07 (71)
Note. Numbers in parentheses are percentages, HCC=hepatocellular carcinoma, PPV=positive predictive value
Table 4. Delayed Phase Acoustic Emission Effect Patterns for Each Diagnosis, and the Corresponding Sensitivity, Specificity,
and PPV Values
Diagnosis Enhancement Patterns Sensitivity Specificity PPV
HCC Inhomogeneous enhancement 36/43 (84) 45/47 (96) 37/39 (95)
Metastasis Hypoechoic, decreased enhancement 28/30 (93) 55/60 (92) 28/33 (85)
Hemangioma Hypoechoic and reversed echogenicity 11/17 (65) 073/73 (100) 011/11 (100)
Hemangioma Isoechoic, homogeneous enhancement 06/17 (35) 72/73 (99) 06/07 (86)
Note. Numbers in parentheses are percentages, HCC=hepatocellular carcinoma, PPV=positive predictive value
Table 3. Patterns of Acoustic Emission Effect at Delayed Phase Pulse-inversion Harmonic US in 90 Patients with HCC,
Metastasis and Hemangioma
Patterns of Acoustic Emission Effect HCC Metastasis Hemangioma Total
Inhomogeneous enhancement 37 02 003 9
Hypoechoic, decreased enhancement 052 8003 3
Hypoechoic and reversed echogenicity 00 001 1 1 1
Isoechoic, homogeneous enhancement 01 00 06 07
Total 43 30 17 90
Note. HCC=hepatocellular carcinomathan Levovist for vascular imaging because of their stabili-
ty (16); Levovist, however, because of its unique liver-spe-
cific action, is considered better at providing the stimulated
acoustic emission effect at delayed phase imaging (18).
Secondly, for delayed phase pulse-inversion imaging we
used a high MI, not the interval delay procedure. Kim et al.
(14) recently reported that PIHI with an interval delay
technique was useful for the characterization of hepatic tu-
mors. Although they found that the technique demonstrat-
ed specific enhancement features of hepatic hemangiomas,
it was not suitable for demonstrating malignant hepatic tu-
mors such as HCCs and metastases. Ko et al. (19), on the
other hand, showed that delayed phase imaging with gray-
scale stimulated acoustic emission might be useful for dif-
ferentiating between HCC and metastatic adenocarcinoma
of the liver.
In our study, vascular phase imaging with a low MI de-
tected the morphological characteristics of tumoral vessels.
During delivery of the contrast agent, enhanced signals
were emitted by both normal hepatic and lesional blood
vessels. In HCCs, the ‘internal vessels’ pattern was striking;
the characteristics of these vessels were distinct, unlike
those of hemangiomas and metastatic tumors. Jang et al.
(15) found that at the vascular imaging phase of the coded
harmonic angio technique, a majority of HCCs were de-
picted as irregular branching vessels or showed randomly
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Fig. 6. Metastasis from stomach cancer, exhibiting the ‘hypoechoic, decreased enhancement’ pattern on delayed phase image.
A. Pulse-inversion harmonic US image obtained prior to contrast injection depicts a hypoechoic nodule (arrow).
B. Delayed phase image (high MI) shows a hypoechoic mass with decreased enhancement (arrow) compared to homogenous bright
echogenic hepatic parenchyma.
AB
Fig. 7. Hemangioma demonstrating ‘hypoechoic and reversed echogenicity’ at the delayed phase.
A. Conventional sonogram depicts a hyperechoic hepatic nodule (arrow).
B. Delayed phase pulse-inversion harmonic image reveals a hypoechoic nodule with decreased enhancement compared to adjacent liv-
er (arrow), and hypoechoic and reversed echogenicity at stimulated acoustic emission imaging.
ABstippled vascularity. We believe that even though the US
technique employed was somewhat different, their vascu-
lar phase imaging findings and ours were similar. For he-
mangiomas, the observed pattern was ‘peripheral nodular
enhancement’ or ‘minimal or no enhancement’; in no case
were internal or marginal vessels observed. As in previous
studies (14 16), our results showed that ‘peripheral nodu-
lar enhancement’, observed at vascular phase imaging, was
a highly specific finding for the diagnosis of hemangiomas.
However, for five of the 17 tumors fo this kind, the ob-
served pattern was ‘minimal or no enhancement’, a result
different from that of previous studies (14 15). We be-
lieve our results were due to the relatively low sensitivity
of the PIHI technique itself when used to evaluate the vas-
cularity of hemangiomas, the dosage of the contrast agent
injected, and the histologic characteristics of the tumor.
At delayed phase imaging with a high MI using PIHI, the
intensity of the echo was proportional to the number of
microbubbles present within the ultrasound beam, reflect-
ing the amount of microbubbles in a tumor’s sinusoids and
Kupffer cells (11). Although not certain, it is thought that
microbubbles are simply retained in the sinusoidal spaces
or are encapsulated by Kupffer cells (12). Because the ma-
jority of hepatic tumors do not contain sinusoids or
Kupffer cells, these tumors appear at stimulated acoustic
emission imaging as defects or signal loss compared to nor-
mal hepatic parenchyma. HCCs do not usually contain
Kupffer cells, though some types, such as well-differentiat-
ed HCC and early HCC, may contain a portion of normal-
appearing hepatocytes or Kupffer cells. Profuse intratu-
moral vessels, as well as the sinusoids and reticuloendothe-
lial cells within some types of HCC, might thus appear as
bright emission signals, the so-called ‘inhomogeneous en-
hancement’ seen on delayed phase images. In our study,
86% of HCCs showed inhomogeneous enhancement, a re-
sult somewhat different from those of previous studies (15,
16), in which a hypoechoic washout pattern or no en-
hancement was observed at interval delay or postvascular
imaging.
The majority of metastases were seen as ‘hypoechoic, de-
creased enhancement’, indicating that metastatic tumors
are usually hypovascular and do not contain reticuloen-
dothelial cells. In some hepatic metastases, however,
acoustic emission signals were present at their periphery;
this was thought to represent capillarization of the sinu-
soid, and peripheral fibrosis of the hepatic parenchyma
(21). Although a small minority of the metastases in our
study showed inhomogeneous enhancement, in 93% of
cases the observed pattern was ‘hypoechoic, decreased en-
hancement’, a finding similar to those previously reported
(14 17).
All hemangiomas showed one of two patterns, namely
‘decreased and reversed echogenicity’ or ‘isoechoic, homo-
geneous enhancement’. The former indicated that a lesion
which was echogenic to surrounding liver at baseline imag-
ing became echo-poor at delayed imaging, suggesting that
hemangiomas have fewer sinusoids than normal liver.
Hemangiomas showing ‘isoechoic, homogeneous enhance-
ment’, on the other hand, were those with large sinusoidal
spaces, as described by Yamashita et al. (20). As stated
above, hemangioma-related findings at interval delay
imaging are specific. The histopathology of hemangiomas
varies, however, according to their tissue components and
vascular pools, and the imaging findings thus present a
spectrum, with various patterns observed at dynamic con-
trast-enhanced CT or MR. We therefore believe that de-
layed phase imaging of hemangiomas may demonstrate
various patterns, and in order to evaluate tissue character-
istics in terms of the relationship between histologic fea-
tures and delayed-phase PIHI findings, further study may
be warranted.
This study suffers certain limitations. Firstly, SH U 508
A, used as a contrast agent, is known to have a weak har-
monic response when insonated with an ultrasound beam
at a low MI (16). The microbubbles are destroyed even at
continuous vascular phase imaging, for which Levovist is a
less suitable agent. We therefore suggest that in our study,
vascular phase imaging might not have depicted tumoral
vascularity sufficiently. The second limitation is the inher-
ent drawbacks of US techniques used in this study.
Continuous vascular phase US scanning is possible in only
one scanning plane, and in patients with multiple lesions it
is therefore not possible to characterize all lesions simulta-
neously. Nor can delayed phase scanning simultaneously
include all lesions, and since its duration is very short, it is
not easy to obtain the best images depicting the acoustic
emission effect in the same area as vascular phase images.
In conclusion, vascular and delayed phase PIHI appears
to be a useful imaging technique for the characterization of
focal hepatic lesions. The depiction of tumoral vascularity
and the acoustic emission effect at dual-phase PIHI after
the injection of a microbubble contrast agent can help dif-
ferentiate HCC, metastasis, and hemangioma.
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